Bibliografia
1) Martin JA, Kirmeyer S, Osterman M, Shepherd RA. Born a Bit Too Early: Recent Trends in Later Preterm Birth. NCHS Data Brief. 2009 Nov;(24):1-8.
2) NCHS Data Brief, no. 24. Hyattsville, MD: National Center for Health Statistics, 2009.
3) Heron M, Sutton PD, Xu J, et al. Annual summary of vital statistics: 2007. Pediatrics 2010;125:4-15.
4) Bettegowda VR, Dias T, Davidoff MJ, et al. The relationship between cesarean delivery and gestational age among US singleton births. Clin Perinatol 2008;35(2):309-323.
5) AAP, ACOG: Standard terminology for reporting of reproductive health statistics in the United States, in Guidelines for Perinatal Care (ed 5; appendix E). Elk Grove, IL, American Academy of Pediatrics and American College of Obstetricians and Gynecologists, 2002, pp 377-394.
6) Shapiro-Mendoza CK, Tomashek KM, Kotelchuck M, et al. Effect of late-preterm birth and maternal medical conditions on newborn morbidity risk. Pediatrics 2008;121:e223-e232.
7) McLaurin KK, Hall CB, Jackson EA, et al. Persistence of morbidity and cost differences between late-preterm and term infants during the first year of life. Pediatrics 2009;123(2):653-659.
8) Friedrich L, Stein RT, Pitrez PMC, et al. Reduced lung function in healthy preterm infants in the first months of life. Am J Respir Crit Care Med 2006; 173:442-447.
9) Engle, WA. A recommendation for the definition of “late preterm” (near-term) and the birth weight-gestational age classification system. Seminars in Perinatology 2006; 30:2.
10) Martin RJ, Fanaroff A, Walsh, M. Fanaroff and Martin’s neonatal-perinatal medicine (8th ed.). St. Louis: Mosby Inc. (2006).
11) Hanson L, Korotkova M, Lundin S. The transfer of immunity from mother to child. Annals of New York Academy of Sciences, 2003; 987:199-206.
12) Medici MC, Arcangeletti MC, Rossi GA, Lanari M, Merolla R, Paparatti UD, Chezzi C, Osservatorio VRS Study Group (2000-2004). Four year incidence of respiratory syncytial virus infection in infants and young children referred to emergency departments for lower respiratory tract diseases in Italy: the “Osservatorio VRS” Study New Microbiol 2006; 29:35-43.
13) Hall CB. Nosocomial respiratory syncytial virus infections: The “Cold War” has not ended. Clinical Infectious Diseases, 2000; 31:590-596.
14) Pickering LK, Baker CF, Long SS, and McMillan JA. (eds). Red Book: 2006 Report of the Committee on Infectious Diseases (27th ed.). Elk Grove Village, IL: American Academy of Pediatrics, 2006.
15) Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. Journal of the American Medical Association, 2003; 289:179-186.
16) Sorce LR. Respiratory syncytial virus: From primary care to critical care. Journal of Pediatric Health Care 2009; 23(2), 101-108.
17) Welliver RC. Respiratory syncytial virus infection: Therapy and prevention. Paediatric Respiratory Reviews, 2004; 5(Suppl. A):S127-S133.
18) Peer-Point Medical Education Institute. (2008a). RSV 203-Severe RSV disease: Diagnosis and management in the pediatric patient. Accessed at http://www.RSVuniversity.com, June 5, 2009.
19) Black CP. Systematic review of the biology and medical management of respiratory syncytial virus infection. Respiratory Care 2003; 48:209-233.
20) Horn SD, Smout RJ. Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes. The Journal of Pediatrics 2003; 143(5):S133-S141.
21) Long S. Principles and practice of pediatric infectious diseases (3rd ed.) Philadelphia: Churchill Livingston/Elsevier (2008).
22) Coffman S. Late preterm infants and risk for RSV. Am J Matern Child Nurs November/ December 2009; 34(6):378-84.
23) American Academy of Pediatrics (AAP). (2006). American Academy of Pediatrics subcommittee on diagnosis and management of bronchiolitis. Pediatrics, 2006; 118:1774-1793.
24) Ventre K, Randolph A. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. The Cochrane Database of Systematic Reviews, 2008; 3:26 pgs.
25) Meissner HC, Bocchini JA, Brady MT, Hall CB, Kimberlin DW, and Pickering LK. The role of immunoprophylaxis in the reduction of disease attributable to Respiratory Syncytial Virus. Pediatrics 2009; 124:1676-2346.
26) American Academy of Pediatrics - Committee on Infectious Diseases. Modified recommendation for use of palivizumab for prevention of Respiratory Syncytial Virus infections. Pediatrics 2009; 124:1694-1701. 27) Rossi GA, Silvestri M, Lanari M. Should the American Academy of Pediatrics Respiratory Syncytial Virus guidelines be modified? Pediatrics 2010; 125(4):1021. 28) Paes B, et al. Predictive value of the respiratory syncytial virus risk-scoring tool in the term infant in Canada. Curr Med Res Opin. 2009 Sep; 25(9):2191-6.
|